NEW YORK (GenomeWeb News) — Bio-Rad Laboratories today said fourth-quarter revenues increased 12 percent as R&D spending rose 20 percent and profit increased 24 percent.
 
Total receipts for the three months ended Dec. 31, 2006, increased to $343 million from $307 million year over year.
 
Revenue from the company’s Life Science division rose 13 percent to $159 million, while receipts from the Clinical Diagnostics segment increased 11 percent to $180 million.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.